Trials / Completed
CompletedNCT01453946
Safety and Maintenance Study of Entocort for Children With Crohn's Disease
A Multicenter, Open Label, Non-comparative Study to Evaluate the Safety of Entocort EC as a Maintenance Treatment for Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 5 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
A Safety for Maintenance of Entocort EC for children with mild to moderate Crohn's Disease.
Detailed description
A Multicenter, Open label, Non-comparative Study to Evaluate the Safety of Entocort EC as a Maintenance Treatment for Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Entocort | Entocort capsules, taken orally, 6 mg daily. |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2011-10-18
- Last updated
- 2022-01-06
- Results posted
- 2015-06-19
Locations
19 sites across 5 countries: United States, Canada, Germany, Italy, Poland
Source: ClinicalTrials.gov record NCT01453946. Inclusion in this directory is not an endorsement.